LOXL2 and ovarian cancer: In ovarian cancer, KDM4B is induced under hypoxia, and deletion of KDM4B increases H3K9me3 level at target gene promoters such as the LOXL2, LCN2, and PDGFB promoters, thereby inhibiting the invasion, migration and globulization of ovarian cancer cells.